Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
ADMS is in the long-term up 41% in 3 years.
Description: Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. The company?s lead product candidate, ADS-5102, is being developed for a complication of Parkinson?s disease, known as levodopa-induced dyskinesia, and as a treatment for chronic behavioral symptoms associated with traumatic brain injury. Its portfolio also includes an NDA-submitted fixed-dose combination product candidate, MDX-8704, which is being co-developed with Forest Laboratories, Inc.; and an approved controlled-release product, Namenda XR. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Emeryville, California.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||-2.84||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-99.1%||Sales Growth - Q/Q||-99.25%||P/E||-6.16|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||2.99%||ROE||3.2%||ROI|
|Current Ratio||14.25||Quick Ratio||Long Term Debt/Equity||Debt Ratio||0.06|
|Gross Margin||Operating Margin||21.43%||Net Profit Margin||7.87%||Dividend Payout Ratio|
|Cash From Financing Activities||300 K||Cash From Investing Activities||-18.45 M||Cash From Operating Activities||-14.06 M||Gross Profit|
|Net Profit||-12.2 M||Operating Profit||-12.23 M||Total Assets||147.34 M||Total Current Assets||115.52 M|
|Total Current Liabilities||8.11 M||Total Debt||Total Liabilities||9.79 M||Total Revenue||230 K|
|High 52 week||42.65||Low 52 week||13.68||Last close||24.16||Last change||1.6%|
|RSI||32.36||Average true range||1.15||Beta||1.4||Volume||92.31 K|
|Simple moving average 20 days||-7.54%||Simple moving average 50 days||-9.49%||Simple moving average 200 days||-16.87%|
|Performance Week||-9.55%||Performance Month||-6.25%||Performance Quart||-19.33%||Performance Half||-36.15%|
|Performance Year||40.71%||Performance Year-to-date||-28.71%||Volatility daily||2.85%||Volatility weekly||6.37%|
|Volatility monthly||13.05%||Volatility yearly||45.2%||Relative Volume||208.74%||Average Volume||562.48 K|
|New High||New Low|
2019-03-12 16:05:00 | Adamas Announces New Employment Inducement Grant
2019-03-05 12:40:00 | Why Adamas Pharmaceuticals Shares Are Crashing Today
2019-03-04 21:51:27 | Edited Transcript of ADMS earnings conference call or presentation 4-Mar-19 9:30pm GMT
2019-03-04 21:34:12 | Adamas Pharmaceuticals Inc ADMS Q4 2018 Earnings Conference Call Transcript
2019-02-26 09:41:02 | Will R&D Focus Fuel DENTSPLY SIRONA's XRAY Earnings in Q4?
2019-02-20 16:50:00 | Adamas to Present at Two Upcoming Investor Conferences
2019-02-20 09:32:02 | Tenet Healthcare THC Q4 Earnings: What's in the Offing?
2019-02-20 08:18:01 | Can Segmental Growth Fuel Veeva Systems' VEEV Q4 Earnings?
2019-02-18 08:18:01 | AptarGroup ATR to Report Q4 Earnings: What's in Store?
2019-02-08 18:49:24 | Adamas Announces New Employment Inducement Grant
2019-02-07 10:34:03 | Is a Beat in Store for Molina Healthcare MOH Q4 Earnings?
2019-02-07 08:15:00 | Report: Exploring Fundamental Drivers Behind Roku, AECOM, 1-800 FLOWERS.COM, Eldorado Resorts, Haverty Furniture Companies, and Adamas Pharmaceuticals — New Horizons, Emerging Trends, and Upcoming Developments
2019-02-01 11:30:00 | LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index
2019-01-10 16:30:00 | Adamas Announces New Employment Inducement Grant
2019-01-10 10:49:30 | Here's Why These Small-Cap Pharma Stocks Lost as Much as 45% in December
2018-12-18 16:30:00 | Adamas Announces Issuance of New U.S. Patent Covering GOCOVRI™
2018-12-17 21:43:35 | Is Adamas Pharmaceuticals Inc ADMS A Good Stock To Buy?
2018-12-11 15:29:00 | Why Adamas Pharmaceuticals, Inc. Stock Continued to Slide in November
2018-11-09 13:49:52 | Adamas to Present at Three November Investor Conferences
2018-11-08 08:30:00 | Factors of Influence in 2018, Key Indicators and Opportunity within Apptio, Adamas Pharmaceuticals, NEXEO SOLUTIONS, Computer Programs and, Solaris Oilfield Infrastructure, and SPX — New Research Emphasizes Economic Growth
2018-11-02 20:10:33 | Edited Transcript of ADMS earnings conference call or presentation 1-Nov-18 8:30pm GMT
2018-11-02 11:37:00 | The Probable Reason Why Adamas Pharmaceuticals Inc. Is Down Big Today
2018-11-01 17:52:30 | Adamas: 3Q Earnings Snapshot
2018-11-01 16:01:00 | Adamas Reports Third Quarter 2018 Financial Results
2018-10-24 13:11:40 | China cutting rare earth output, unnerving global manufacturers
2018-10-16 09:15:00 | Consolidated Research: 2018 Summary Expectations for Freightcar America, Star Bulk Carriers, Avis Budget Group, Adamas Pharmaceuticals, Model N, and Amphastar Pharmaceuticals — Fundamental Analysis, Key Performance Indications
2018-10-12 09:00:00 | Why Adamas Pharmaceuticals, Inc. Stock Sank in September
2018-10-05 17:51:53 | Adamas Announces New Employment Inducement Grant
2018-10-05 13:59:10 | When Can We Expect A Profit From Adamas Pharmaceuticals Inc NASDAQ:ADMS?
2018-09-13 07:33:15 | A Financial Overview of Supernus Pharmaceuticals in September
2018-09-12 16:35:03 | Supernus Pharmaceuticals Garners 89% ‘Buy’ Ratings in September
2018-09-12 16:30:00 | Adamas Announces New Employment Inducement Grant
2018-08-20 08:25:00 | Investor Expectations to Drive Momentum within Mazor Robotics, Kinross Gold, Mimecast, DBV Technologies S.A., Adamas Pharmaceuticals, and Adverum Biotechnologies — Discovering Underlying Factors of Influence
2018-08-08 16:30:00 | Adamas Announces New Employment Inducement Grant
2018-08-03 17:35:12 | Edited Transcript of ADMS earnings conference call or presentation 2-Aug-18 8:30pm GMT
2018-08-02 19:05:11 | Adamas Pharmaceuticals ADMS Reports Q2 Loss, Tops Revenue Estimates
2018-08-02 17:59:25 | Adamas: 2Q Earnings Snapshot
2018-08-02 16:01:00 | Adamas Reports Second Quarter 2018 Financial Results